Related Experiment Video
Updated: Nov 2, 2025

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Ochronotic heart disease leading to severe aortic valve and coronary artery stenosis
Ana K Velez1, Natalie A Gaughan2, Rosmi P Thomas3
1Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Insights
Cardiac ochronosis, a rare complication of alkaptonuria, can cause severe heart issues. This case highlights significant cardiac pigment deposition, emphasizing the need for further research into this underrecognized condition.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Cardiac ochronosis is a rare manifestation of alkaptonuria, a genetic disorder.
- Musculoskeletal effects are well-documented, but cardiac involvement is less understood.
- Existing data primarily comes from case reports and series.
Observation:
- A 64-year-old patient with alkaptonuria presented with dyspnea and weight loss.
- Cardiac evaluation revealed severe aortic stenosis, coronary artery disease, and septal hypertrophy.
- Surgical findings showed extensive ochronotic pigment deposition in the heart and arteries.
Findings:
- Ochronotic pigment deposition significantly impacted the cardiac septum, coronary arteries, and aortic valve.
- The patient exhibited severe aortic stenosis and coronary artery disease.
- Interventricular septal hypertrophy was also noted.
Implications:
- Ochronotic heart disease is an underrecognized complication of alkaptonuria.
- Further research is crucial to understand disease progression and long-term outcomes.
- Investigating outcomes after cardiac surgery (valve replacement, bypass grafting) in these patients is essential.
Abstract:
Cardiac ochronosis is a rare disease, estimated to affect 1 in 250,000 persons. While there is extensive evidence of the musculoskeletal alterations of the disease, cardiac involvement has not been widely studied and most information we currently have derives from case reports and case series. We report the case of a 64-year old patient with a known history of alkaptonuria who presented with dyspnea and weight loss. On evaluation, he was found to have severe aortic stenosis, coronary artery disease, and interventricular septal hypertrophy. Surgery revealed extensive ochronotic pigment deposition affecting the cardiac septum, both internal thoracic arteries, the native coronary arteries, and the aortic valve. Ochronotic heart disease is an often disregarded presentation of alkaptonuria. More information is needed on the course of the disease, as well as long-term outcomes after valve replacement surgery and/or coronary artery bypass grafting in patients with alkaptonuria.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Rheumatic Heart Disease I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Mitral Regurgitation I: Introduction

